Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon | BSE | Healthcare | Biotechnology & Medical Research | ₹470.05B | 109.5x | -1.55 | ₹352.10 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.4% Upside | Upgrade to Pro+ | |
Biocon | NSE | Healthcare | Biotechnology & Medical Research | ₹470.05B | 109.5x | -1.55 | ₹352.25 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.6% Upside | Upgrade to Pro+ | |
Syngene International Ltd BO | BSE | Healthcare | Biotechnology & Medical Research | ₹252.97B | 53.3x | -16.73 | ₹635.55 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Syngene International Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹252.97B | 53.3x | -16.73 | ₹635.50 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.3% Upside | Upgrade to Pro+ | |
Onesource Specialty Pharma | BSE | Healthcare | Biotechnology & Medical Research | ₹206.82B | -1,641.8x | -17.47 | ₹1,806.25 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39% Upside | Upgrade to Pro+ | |
Onesource Specialty Pharma | NSE | Healthcare | Biotechnology & Medical Research | ₹206.82B | -1,641.8x | -17.47 | ₹1,805.90 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.7% Upside | Upgrade to Pro+ | |
Suven Life Sciences | BSE | Healthcare | Biotechnology & Medical Research | ₹45.47B | -24.7x | 0.38 | ₹208.95 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suven Life Sciences Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹45.47B | -24.7x | 0.38 | ₹208.63 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shree Ganesh Remedies | BSE | Healthcare | Biotechnology & Medical Research | ₹6.53B | 30.3x | -1.35 | ₹508.95 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Indo Us Bio-Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹2.69B | 15.1x | 0.15 | ₹134.05 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions | BSE | Healthcare | Biotechnology & Medical Research | ₹1.85B | 71.9x | 0.44 | ₹12.63 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹1.85B | 71.9x | 0.44 | ₹12.66 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivo Bio Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹827.67M | 7.1x | 0.04 | ₹37.45 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jeevan Scientific Technology | BSE | Healthcare | Biotechnology & Medical Research | ₹618M | -21.5x | 0.05 | ₹39.03 | 10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene Biotek | BSE | Healthcare | Biotechnology & Medical Research | ₹317.48M | -24.4x | 0.08 | ₹4.19 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vanta Bioscience | BSE | Healthcare | Biotechnology & Medical Research | ₹145.49M | -3x | 0.03 | ₹23.05 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |